ImmuPharma Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

34.94M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	118.35K	-8.32K	-6.57%
Dec 31, 2020	126.67K	48.74K	62.55%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
hVIVO	54.47M
Bioventix	13.12M
Arecor Therapeutics	5.06M
SkinBioTherapeutics	4.64M
4basebio	1.78M
Aptamer Group	1.20M
Ondine Biomedical	1.18M

Revenue Rankings

ImmuPharma News

16 days ago - AIM Market Roundup: Immupharma, Pebble Beach, Tungsten West - The Armchair Trader
3 months ago - FTSE Flat as Wall Street Gains Fail to Inspire - Investomania
3 months ago - AIM Market Roundup: Trellus Health, Great Western Mining, EMV Capital - The Armchair Trader
6 months ago - AIM Market Roundup: ImmuPharma, Rockfire Resources, Likewise - The Armchair Trader
6 months ago - AIM Market Roundup: Dewhurst, Metir, Tertiary Minerals - The Armchair Trader
6 months ago - AIM Market Roundup: ImmuPharma, N4 Pharma, Versarien - The Armchair Trader
7 months ago - AIM Market Roundup: Catenai, Europa Oil & Gas, Faron Pharma - The Armchair Trader
7 months ago - FTSE Rises as Investors Eye Tariff Deadline - Investomania

More News